fda warning letter compounding pharmacy bpc-157 Is Diving Deeper in GMP Compliance for Pharmacies – A Follow-up FDA Compliance for Peptide Therapy

doi: 10.3389/fmed.2016.00038 Received 03 July 2016 Accepted 09 August 2016 Published 23 August 2016 Volume 3 - 2016 Edited by Mohammed Morad, Clalit Health Services, Israel Reviewed by Luciana Hannibal, University Medical Center Freiburg, Germany

The vial contains 1,000 mcg

Your healthcare provider can help determine if a specific peptide is safe for your condition

This formula can be administered via IV, IM, or SubQ injection

Animal studies demonstrate enhanced collagen organization and improved biomechanical strength in healing tendons treated with the peptide

suggested a difference in the individual MTHFR gene variation ( In contrast to the aforementioned study ( Importantly, we did not preselect patients based on a positive response to previous vitamin B12 injections, leading to more generalizable results in our study